The quantity of ligand-receptor interactions between nanoparticles and target cells

Area of Science:

• Biomedical engineering
• Nanotechnology
• Molecular biology

Background:

• Achieving high target cell avidity and selectivity is crucial for biomedical nanoparticle systems.
• Viruses, with their low number of binding domains, serve as models for efficient nanoparticle design.
• Current nanoparticles often have a significantly higher ligand density than viruses, potentially hindering efficiency.

Purpose of the Study:

• To determine the number of ligands per nanoparticle involved in specific binding with target cell receptors.
• To investigate the relationship between ligand density and binding efficiency in nanoparticle systems.
• To provide experimental data for optimizing ligand number on nanoparticles.

Main Methods:

• Utilized a block copolymer nanoparticle model system for experimental analysis.
• Quantified the total ligand valency on the nanoparticle surface.
• Measured the number of ligands involved in specific receptor binding.

Main Results:

• Confirmed that only a fraction of nanoparticle ligands participate in specific binding.
• Found a maximum of 5.3 ligands/100 nm² involved in specific binding, out of 29 total ligands/100 nm².
• Calculated an average of 251 binding ligands per nanoparticle, providing biological context.

Conclusions:

• Optimizing the number of ligands on nanoparticle surfaces is essential for enhancing avidity and selectivity.
• Understanding the fraction of actively binding ligands is a critical step towards more efficient nanoparticle design.
• The findings offer insights into rational design principles for biomedical nanoparticles based on viral strategies.